Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study

Overview of attention for article published in Frontiers in immunology, October 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 51,037 followers.

RT @reumacia: Análisis transcriptómico 🧬 de pacientes con artritis psoriásica en remisión 📊 Acceso abierto 🔑 https://t.co/xo3vMpCgiH https:…

RT @reumacia: Análisis transcriptómico 🧬 de pacientes con artritis psoriásica en remisión 📊 Acceso abierto 🔑 https://t.co/xo3vMpCgiH https:…

Análisis transcriptómico 🧬 de pacientes con artritis psoriásica en remisión 📊 Acceso abierto 🔑 https://t.co/xo3vMpCgiH https://t.co/fhVINY0xgA

RT @FrontImmunol: New Research: Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 ge…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.